Bristol-Myers Squibb Company (BMY) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Bristol-Myers Squibb shareholders at a glance

The largest holder of Bristol-Myers Squibb stock is Vanguard Capital Management LLC, with 133.3 million shares (6.53% of the company), worth about $8.91 billion as of September 25, 2026. The 10 largest holders together own 35.5%.

In Q2 2026, 2,647 institutional holdings reports listed 1.86 billion shares worth $108.00 billion, up 14.8% in shares from Q1 2026.

Insiders reported 58 transactions in the last two years: 7 sales worth $5.00 million and 4 purchases. The newest one on file is from September 9, 2026 (Massacesi Cristian, Officer).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 9, 2026.

BMY logo

Bristol-Myers Squibb Company

BMYUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
2647
Options Value
$2.65B
Value (excl. Options)
$108.00B
Shares (excl. Options)
1.86B

Ownership by Type

Geographic Distribution

Largest Bristol-Myers Squibb shareholders

HolderShares% of companyValue
Vanguard Capital Management LLC133.3 million6.53%$8.9B
BlackRock Advisors LLC129.2 million6.32%$8.6B
State Street Corporation102.4 million5.01%$6.8B
JPMorgan Investment Management, Inc.71.7 million3.51%$4.8B
Charles Schwab Investment Management, Inc.67.6 million3.31%$4.5B
Geode Capital Management LLC56.4 million2.76%$3.8B
Vanguard Portfolio Management LLC46.9 million2.29%$3.1B
BlackRock Life Ltd.46.2 million2.26%$3.1B
Norges Bank (13F)36.9 million1.80%$2.5B
Merrill Lynch International34.1 million1.67%$2.3B

As of September 25, 2026.

Bristol-Myers Squibb institutional holdings by quarter

QuarterReportsSharesValue
Q2 20262,6471.86 billion$108.0B
Q1 20262,6711.62 billion$98.1B
Q4 20252,5761.65 billion$88.8B
Q3 20252,4151.67 billion$75.5B
Q2 20252,4291.66 billion$76.9B
Q1 20252,6101.64 billion$99.7B
Q4 20242,6181.60 billion$90.5B
Q3 20242,3951.64 billion$84.5B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Bristol-Myers Squibb insider trades

InsiderDateTitleTransactionValue
Massacesi CristianSep 9, 2026OfficerSale at price 64.57 per share.$403,498
Short Bartie WendySep 1, 2026OfficerConversion of Exercise of derivative security at price 66.92 per share.$82,713
Holzer Phil MAug 25, 2026OfficerSale at price 67.50 per share.$33,750
Massacesi CristianJul 31, 2026Officer--–
Gallman CariJul 31, 2026General Counsel--–
Haller Julia AJun 15, 2026DirectorConversion of Exercise of derivative security at price 53.76 per share.$1.1M
Short Bartie WendyJun 3, 2026Officer--–
Lenkowsky AdamMay 1, 2026Officer--–
Elkins David VincentApr 1, 2026Chief Financial OfficerSale at price 61.60 - 62.05 per share.$1.9M
Shanahan KarinApr 1, 2026Officer--–
Short Bartie WendyMar 10, 2026Officer--–
Lenkowsky AdamMar 10, 2026Officer--–

Newest 12 of 58 insider transactions in the last two years.

Questions and answers

Who owns the most Bristol-Myers Squibb stock?

Vanguard Capital Management LLC, with 6.53% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.32%) and State Street Corporation (5.01%).

How many institutions own Bristol-Myers Squibb stock?

2,647 institutional holdings reports listed Bristol-Myers Squibb shares in Q2 2026, 1.86 billion shares in all worth $108.00 billion.

Are Bristol-Myers Squibb insiders buying or selling the stock?

In the last two years insiders reported 7 sales and 4 purchases (58 transactions in all); the newest on file is from September 9, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube